These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 39289933)
1. DDP Induced Cytotoxicity through miR-215-5p/COL5A1/FSTL1 Axis to Regulate Autophagy in Lung Adenocarcinoma Cells. Zhao X; Zhang H; Gu L; Zhang H; Cao H Curr Pharm Biotechnol; 2024 Sep; ():. PubMed ID: 39289933 [TBL] [Abstract][Full Text] [Related]
2. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis. Xie H; Yao J; Wang Y; Ni B Drug Deliv; 2022 Dec; 29(1):1257-1271. PubMed ID: 35467477 [TBL] [Abstract][Full Text] [Related]
3. Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55. Fu L; Li Z; Wu Y; Zhu T; Ma Z; Dong L; Ding J; Zhang C; Yu G Biochem Genet; 2023 Aug; 61(4):1528-1547. PubMed ID: 36658310 [TBL] [Abstract][Full Text] [Related]
4. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy, Invasion, and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells. Yao W; Guo P; Mu Q; Wang Y Cancer Biother Radiopharm; 2021 May; 36(4):347-359. PubMed ID: 32799541 [No Abstract] [Full Text] [Related]
5. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma. Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670 [TBL] [Abstract][Full Text] [Related]
6. DICER activates autophagy and promotes cisplatin resistance in non-small cell lung cancer by binding with let-7i-5p. Li C; Chen L; Song W; Peng B; Zhu J; Fang L Acta Histochem; 2021 Oct; 123(7):151788. PubMed ID: 34543777 [TBL] [Abstract][Full Text] [Related]
7. mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9. Liu B; Wang R; Liu H Biomed Res Int; 2021; 2021():6622342. PubMed ID: 34055989 [TBL] [Abstract][Full Text] [Related]
8. miR-125b-5p upregulation by TRIM28 induces cisplatin resistance in non-small cell lung cancer through CREB1 inhibition. Tan Q; Ma J; Zhang H; Wu X; Li Q; Zuo X; Jiang Y; Liu H; Yan L BMC Pulm Med; 2022 Dec; 22(1):469. PubMed ID: 36476351 [TBL] [Abstract][Full Text] [Related]
9. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs). Liu X; Zhou X; Chen Y; Huang Y; He J; Luo H Neoplasma; 2020 Jan; 67(1):147-157. PubMed ID: 31686523 [TBL] [Abstract][Full Text] [Related]
10. miR-125b reverses cisplatin resistance by regulating autophagy via targeting RORA/BNIP3L axis in lung adenocarcinoma. Liu L; Guo NA; Li X; Xu Q; He R; Cheng L; Dang C; Bai X; Bai Y; Wang X; Chen Q; Zhang LI Oncol Res; 2024; 32(4):643-658. PubMed ID: 38560570 [TBL] [Abstract][Full Text] [Related]
11. Circ_0010235 confers cisplatin resistance in lung cancer by upregulating E2F7 through absorbing miR-379-5p. Wang L; Wang D; Xu Z; Qiu Y; Chen G; Tan F Thorac Cancer; 2023 Jul; 14(20):1946-1957. PubMed ID: 37277864 [TBL] [Abstract][Full Text] [Related]
12. CircRNA ZKSCAN1 promotes lung adenocarcinoma progression by miR-185-5p/TAGLN2 axis. Yu N; Gong H; Chen W; Peng W Thorac Cancer; 2023 Jun; 14(16):1467-1476. PubMed ID: 37105934 [TBL] [Abstract][Full Text] [Related]
13. microRNA-486-5p Regulates DNA Damage Inhibition and Cisplatin Resistance in Lung Adenocarcinoma by Targeting AURKB. Sun G; Ni K; Shen J; Liu D; Wang H Crit Rev Eukaryot Gene Expr; 2024; 34(4):13-23. PubMed ID: 38505869 [TBL] [Abstract][Full Text] [Related]
14. Suppression of ZNF205-AS1/EGR4 positive feedback loop attenuates cisplatin resistance of non-small cell lung cancer cells via targeting miR-138-5p/OCT4 pathway. Li H; Jin Y; Zhu Y; Shen B; Xu Y J Thorac Dis; 2024 Jan; 16(1):296-310. PubMed ID: 38410545 [TBL] [Abstract][Full Text] [Related]
15. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner. Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364 [TBL] [Abstract][Full Text] [Related]
16. SNHG15 enhances cisplatin resistance in lung adenocarcinoma by affecting the DNA repair capacity of cancer cells. Li Y; Huang HQ; Huang ZH; Yu ND; Ye XL; Jiang MC; Chen LM Diagn Pathol; 2023 Mar; 18(1):33. PubMed ID: 36864456 [TBL] [Abstract][Full Text] [Related]
17. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis. Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072 [TBL] [Abstract][Full Text] [Related]
18. ELF1 suppresses autophagy to reduce cisplatin resistance via the miR-152-3p/NCAM1/ERK axis in lung cancer cells. Zhao L; Wu X; Zhang Z; Fang L; Yang B; Li Y Cancer Sci; 2023 Jun; 114(6):2650-2663. PubMed ID: 36846943 [TBL] [Abstract][Full Text] [Related]
19. CircRNA_100565 contributes to cisplatin resistance of NSCLC cells by regulating proliferation, apoptosis and autophagy via miR-337-3p/ADAM28 axis. Zhong Y; Lin H; Li Q; Liu C; Shen J Cancer Biomark; 2021; 30(2):261-273. PubMed ID: 33682697 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-106a-5p alleviated the resistance of cisplatin in lung cancer cells by targeting Jumonji domain containing 6. Ge X; Jiang Y; Hu X; Yu X Transpl Immunol; 2021 Dec; 69():101478. PubMed ID: 34607003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]